The therapy is administered via a one-time intravenous infusion, which is designed to elicit the production of therapeutic levels of factor VIII.
The preliminary injunction was part of an ongoing patent lawsuit.
The activity will examine the technology behind the emerging approaches to gene therapy in hemophilia.
The company stated that it is their intent to provide enough advanced notice of the discontinuation to allow patients to transition to a suitable alternative therapy
This CME and CNE-accredited activity reviews the basic science behind the development of inhibitor antibodies to treatment for hemophilia, and more.
A new patient financial assistance program has become available for individuals with hemophilia.
HANDI, NHF’s information resource center, highlights resources aimed for new college students.
NHF submitted a letter on the "American Patients First" drug pricing blueprint.
The HTRS MRA provides financial support for qualified fellows or junior attending/junior faculty pursuing clinical, translational, or basic science research in hemostasis and/or thrombosis under the guidance of an experienced mentor.
Emory HTC researchers uncovered some noteworthy findings in this unique study on clinic non-attendance rates, including a small at-risk subgroup that may warrant further investigations.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car